SDS

Monsanto Company, Lawn & Garden Products
Page: 2 / 10
Roundup® Weed & Grass Killer Concentrate Plus Version: 2.0 Effective date: 11/04/2015
Dispose of contents/container in accordance with local, regional, national and international
regulations.
2.3. Appearance and odour (colour/form/odour)
Amber /Liquid / Musky
2.4. OSHA Status
This product is hazardous according to the OSHA Hazard Communication Standard, 29 CFR 1910.1200.
Refer to section 11 for toxicological and section 12 for environmental information.
3. COMPOSITION/INFORMATION ON INGREDIENTS
Active ingredient
Isopropylamine salt of N-(phosphonomethyl)glycine; {Isopropylamine salt of glyphosate}
6,7-Dihydrodipyrido(1,2-a:2',1'c) pyrazinedium dibromide; {Diquat dibromide}
Composition
COMPONENT CAS No. % by weight (approximate)
Isopropylamine salt of glyphosate 38641-94-0 18
Diquat dibromide 85-00-7 0.73
Other ingredients 81.27
The specific chemical identity is being withheld because it is trade secret information of Monsanto Company.
4. FIRST AID MEASURES
Use personal protection recommended in section 8.
4.1. Description of first aid measures
4.1.1. Skin contact: Take off contaminated clothing. Rinse skin immediately with plenty of water for 15-
20 minutes. Call a poison control center or doctor for treatment advice.
4.1.2. Inhalation: If inhaled, move person to fresh air. If person is not breathing, call emergency number or
ambulance, then give artificial respiration, preferably mouth-to-mouth, if possible. Call a poison
control center or doctor for treatment advice.
4.1.3. Ingestion: Call poison control center or doctor immediately for treatment advice. Have person sip a
glass of water if able to swallow. Do not induce vomiting unless told to do so by the poison center or
doctor. Do not give anything by mouth to an unconscious person.
4.2. Most important symptoms and effects, both acute and delayed
4.2.1. Eye contact, short term: May cause temporary eye irritation.
4.2.2. Skin contact, short term: Not expected to produce significant adverse effects when recommended
use instructions are followed.
4.2.3. Inhalation, short term: Not expected to produce significant adverse effects when recommended use
instructions are followed.
4.2.4. Single ingestion: Not expected to produce significant adverse effects when recommended use
instructions are followed.
4.3. Indication of any immediate medical attention and special treatment needed